Bellerophon Therapeutics, Inc. (BLPH) Financials
BLPH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 5.0 million | 1.3 million |
2023-06-30 | 11.2 million | 5.6 million |
2023-03-31 | 16.0 million | 5.4 million |
2022-12-31 | 7.9 million | 5.4 million |
BLPH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.3 million | 21000 |
2023-06-30 | -4.9 million | 133000 |
2023-03-31 | 3.3 million | 264000 |
2022-12-31 | -4.4 million | 162000 |
BLPH Net Income
No data available :(
BLPH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 4.4 million | - | - |
2023-06-30 | 10.6 million | - | - |
2023-03-31 | 15.2 million | - | 8000 |
2022-12-31 | 6.9 million | - | 203000 |
BLPH Shares Outstanding
BLPH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 544000 | 1.6 million | - |
2023-06-30 | - | 2.9 million | 2.4 million | - |
2023-03-31 | - | 2.6 million | 1.6 million | - |
2022-12-31 | - | 3.7 million | 1.4 million | - |
BLPH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | 5.6 million | - |
2022-12-31 | - | - |
BLPH
Price: $0.06
52 week price:
Earnings Per Share: -0.89 USD
P/E Ratio: -0.07
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 18100
Ebitda: -6.1 millionMarket Capitalization: 733956